Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor
about
IP-10 induces dissociation of newly formed blood vesselsChemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous ScarringThe Role of Chemokines in Fibrotic Wound HealingChemokine Regulation of Angiogenesis During Wound HealingThe Beginning of the End: CXCR3 Signaling in Late-Stage Wound HealingPKCδ localization at the membrane increases matrix traction force dependent on PLCγ1/EGFR signalingCXCL10 can inhibit endothelial cell proliferation independently of CXCR3.Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarringA novel role of peripheral corticotropin-releasing hormone (CRH) on dermal fibroblastsDelayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR3.CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycansAn IP-10 (CXCL10)-derived peptide inhibits angiogenesis.Skin wound healing and scarring: fetal wounds and regenerative restitution.Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.Delayed cutaneous wound closure in HO-2 deficient mice despite normal HO-1 expressionCXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.Pericyte regulation of vascular remodeling through the CXC receptor 3Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.Skin tissue repair: Matrix microenvironmental influences.ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair.Epidermal growth factor protects fibroblasts from apoptosis via PI3 kinase and Rac signaling pathways.The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKDMatrix control of scarring.Pericytes: A newly recognized player in wound healing.NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation.Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasisUstekinumab: a review of its use in the management of moderate to severe plaque psoriasis.CXCL11 Expression by Keratinocytes Occurs Transiently Between Reaching Confluence and Cellular Compaction.Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization.Thymus and activation-regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration.Local Probiotic Therapy with Lactobacillus plantarum Mitigates Scar Formation in Rabbits after Burn Injury and Infection.Differential regulation of pericyte function by the CXC receptor 3.Loss of epidermal AP1 transcription factor function reduces filaggrin level, alters chemokine expression and produces an ichthyosis-related phenotype.Transplanted fibroblasts prevents dysfunctional repair in a murine CXCR3-deficient scarring model.Multipotent stromal cells/mesenchymal stem cells and fibroblasts combine to minimize skin hypertrophic scarring.Induction of the CXC chemokine interferon-gamma-inducible protein 10 regulates the reparative response following myocardial infarction.Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound Healing.Improved Transplanted Stem Cell Survival in a Polymer Gel Supplemented With Tenascin C Accelerates Healing and Reduces Scarring of Murine Skin Wounds.
P2860
Q24314328-7B24DBEC-0F6B-4EE2-8EF1-29C0377EE9D8Q26778684-A134800D-74DF-48B8-8018-5445D1A5F8A2Q26778686-E56C525E-5C60-4EDF-8582-6B5FC8528CB5Q26778691-FBD0A993-CF0D-4984-89B7-F5E6C152F998Q26830246-E467C2EF-5A57-4A32-85B3-5C9DCFFC89D0Q27303898-FEC08900-6753-42A4-BB17-EA7D4F3ACA33Q33698057-B02C8787-4F36-44FC-B35E-02C08AE02FA5Q33745172-0777B04D-5FDC-4F90-AA18-2D440259EA4AQ33963801-7470865B-7460-4E55-90D2-A30672D7B6ABQ34083641-5B75E6E8-BB1E-4A58-84F5-8BDE455799FAQ34106221-29598129-F54F-4946-A4DE-0BF2796C1CD3Q34345236-6EB1AF27-B5DA-4EF2-9334-D986CEAED890Q34383439-61B21FFE-28EB-475C-BB30-05896428701DQ34476397-D3371857-4E6C-4338-9B43-316C41ACD9DDQ34998399-99E253D8-C844-48EF-9379-500DB32682B0Q35190645-A6BD7C3F-1E0B-47B3-B5B9-776BD6640683Q35193773-B7824E8D-3DD5-4F17-A466-18F0DACFEB5BQ36112820-B2C323D3-16A4-4655-BC01-DB61DB67E489Q36355677-3B9470A1-321A-4D8D-9221-9D9CFFD77737Q36578846-B2CD026D-2309-4C01-A346-352AD1AB4E13Q36855716-D470C804-B710-452C-A103-98FBBE95D6FCQ36899718-54298890-501A-40A7-A7B6-3CBDF586A3CCQ37052067-6BE9EE19-75B8-4A37-A70F-7DD3D7607925Q37123263-6B435500-E15B-490D-8A3F-4242D389EC41Q37150483-D0AE056F-70DB-450C-A6A1-8B635808100AQ37282939-62B6CBE1-84B9-4979-AB18-17E1CBE914BFQ37296078-07B3D602-C71F-4074-B783-F7D6AD455D79Q37730957-2F3EB522-55DE-4156-AA6F-4E7CE0A08B53Q37929165-C93EF56E-F8EA-4ADE-8C3F-711382600AB8Q38721770-43E2D678-BB6A-4630-B407-E202FE41210EQ38948540-2727648E-4630-41D2-89F0-36638B4037B3Q39552590-1527C408-A38E-4EFD-9F67-C665866C1DAEQ40481785-337C52A6-A770-4DEC-AE85-2498837B9C6EQ40700201-3718A103-67FB-49A0-BA16-BCFC40C1D0A6Q41084067-7754100D-D845-4145-8D85-2A752C20E5B5Q41528721-2739C96C-4DA0-4389-8A44-CE99F12E8FA8Q41625413-E9ED54A7-D000-41B4-895B-8B93DC2DE7ACQ42278450-709276F4-478D-480A-B192-0808014F592BQ42862270-A5352E13-F40F-4F9C-A3B1-640C0EC0A6CDQ43051578-454746BB-497D-442D-A330-CD6D7885AE8F
P2860
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@ast
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@en
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@nl
type
label
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@ast
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@en
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@nl
prefLabel
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@ast
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@en
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@nl
P2093
P2860
P1476
Delayed and deficient dermal m ...... egative CXC chemokine receptor
@en
P2093
Alan Wells
Cecelia C Yates
Diana Whaley
Joseph Newsome
Patricia A Hebda
Priya Kulasekeran
Richard Bodnar
Wayne W Hancock
P2860
P304
P356
10.2353/AJPATH.2007.061092
P407
P577
2007-08-01T00:00:00Z